The upregulation of ANGPT found in our RNASeq analysis is consistent with studies using mouse models wherein an increased expression of angiopoietins (ANGPT1, ANGPT2, and ANGPT4 and TIE2 (angiopoietin receptor) have been shown to promote ovarian cancer progression [44]. The gene discussed is ANGPT4; the disease is ovarian carcinoma.